Literature DB >> 12577425

[Immunomodulatory activity and anti-tumor activity of Oldenlandia diffusa in vitro].

B E Shan1, J Y Zhang, X N Du.   

Abstract

OBJECTIVE: To study the effect of Oldenlandia diffusa (OD) on lymphocytes and tumor cells in vitro.
METHODS: Effects of OD extract (ODE) on proliferation of spleen cells of mice and the phagocytosis of monocytes to tumor cells using 3H incorporation were analysed, and effect on specific activity of natural killer (NK) cells to human and mice's tumor cells was determined using free 51 Cr experiments, effects on B cells' antibody production and cytokine of monocyte production were investigated by ELISA and biological method, the chemical composition of OD was analyzed by chromatography, protease digestion and sugar decomposition (NaIO4) test.
RESULTS: ODE could vigorously promote the proliferative activity of spleen cells in mice, specific lethal activity of human and mice's NK cell to tumor cells, B cells' antibody production, monocytes' cytokine production and its phagocytosis to remove the tumor cells. By means of chromatography, protease E digestion and NaIO4 treatment, the result of chemical composition analysis showed that the component of OD was 90 kDa glycoprotein.
CONCLUSION: ODE has immuno-modulating activity and anti-tumor activity in vitro through stimulating the immune system to kill or engulf tumor cells, which could be used clinically for immune function modulation and to treat tumor and other diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12577425

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Differentiation of Hedyotis diffusa and Common Adulterants Based on Chloroplast Genome Sequencing and DNA Barcoding Markers.

Authors:  Mavis Hong-Yu Yik; Bobby Lim-Ho Kong; Tin-Yan Siu; David Tai-Wai Lau; Hui Cao; Pang-Chui Shaw
Journal:  Plants (Basel)       Date:  2021-01-15

2.  The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro.

Authors:  Feifei Pu; Fengxia Chen; Song Lin; Songfeng Chen; Zhicai Zhang; Baichuan Wang; Zengwu Shao
Journal:  Onco Targets Ther       Date:  2016-01-11       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.